| 3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-2-[1-[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]pentan-2-yl]-1,3-diazaspiro[4.4]non-1-en-4-one |
厄贝沙坦杂质 |
1346598-52-4 |
| (1R)-1-(5-methylnaphthalen-1-yl)ethan-1-amine |
西那卡塞杂质 |
1344557-18-1 |
| Fingolimod Impurity A Hydrochloride |
芬戈莫德杂质A盐酸盐 |
1343408-33-2 |
| rac-Sitagliptin EP Impurity B HCl |
rac-Sitagliptin EP Impurity B HCl |
1334244-32-4 |
| Sitagliptin impurity H HCl |
西他列汀杂质 H HCl |
1334244-24-4 |
| 2-ThiophenecarboxaMide, 5-chloro-N-[(2S)-2-hydroxy-3-[[4-(3-oxo-4-Morpholinyl)phenyl]aMino]propyl]- |
利伐沙班杂质48 |
1325210-62-5 |
| (3aR,4S,7R,7aS)-2-[[(1S,2R)-2-[[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione |
(3AR,4S,7R,7AS)-2-[[(1S,2R)-2-[[4-(1,2-苯并异噻唑-3-基)-1-哌嗪基]甲基]环己基]甲基]六氢-4,7-甲桥-1H-异吲哚-1,3(2H)-二酮 |
1318074-19-9 |
| Pentanamide, N-(diazirino[1,3-f]phenanthridin-4-ylmethyl)-N-(2-methylpropyl)- |
Pentanamide, N-(diazirino[1,3-f]phenanthridin-4-ylmethyl)-N-(2-methylpropyl)- |
1314799-75-1 |
| Fasudil Impurity 37 |
Fasudil Impurity 37 |
1314322-31-0 |
| Phenylephrine Impurity 32 |
苯肾上腺素杂质 32 |
1312706-19-6 |
| Phenylephrine Impurity 33 |
苯肾上腺素杂质 33 |
1312706-18-5 |
| Ebastine EP Impurity E |
Ebastine EP Impurity E |
1312211-93-0 |
| Dabigatran Impurity 10 (DABRC-10) |
达比加群杂质10(DABRC-10) |
1304574-20-6 |
| Pazopanib Impurity 9 |
帕唑帕尼杂质9 |
1296888-47-5 |
| Sorafenib Impurity 11 |
Sorafenib Impurity 11 |
1290546-48-3 |
| Ceftaroline Fosamil Impurity 1 |
头孢洛林酯杂质1 |
1286218-72-1 |
| Ceftaroline Fosamil Impurity 3 |
头孢洛林杂质A |
1286218-70-9 |
| Ceftaroline Fosamil Impurity 5 |
头孢洛林杂质3 |
1286218-68-5 |
| Ceftaroline Fosamil Impurity 7 |
头孢洛林酯杂质3 |
1286218-64-1 |
| Ceftaroline Fosamil Impurity 8 |
头孢洛林杂质 3 |
1286218-63-0 |
